Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate in Chronic HBV Patients Treated for 2 Years

Press/Media: Press / Media

Period2021 Nov 21

Media coverage

1

Media coverage